β-Glucuronidase-IN-1 is a highly potent, specific, uncompetitive, and orally bioavailable E. coli bacterial β-glucuronidase inhibitor, exhibiting an IC50 and a Ki of 283 nM and 164 nM, respectively. References: [1]. Wallace BD, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.Science. 2010 Nov 5;330(6005):831-5.

纯度：≥98%

CAS：484006-66-8